<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Encounter Summary</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Encounter Details</a></li><li><a href="#id2">Social History</a></li><li><a href="#id3">Last Filed Vital Signs</a></li><li><a href="#id4">Patient Instructions</a></li><li><a href="#id5">Progress Notes</a></li><li><a href="#id6">Plan of Treatment</a></li><li><a href="#id7">Visit Diagnoses</a></li><li><a href="#id8">Care Teams</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Encounter Details</a></h3><div><table><colgroup><col width="10%"/><col width="15%"/><col width="25%" span="3"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter1" class="xRowNormal"><td>[REDACTED] 10:00 AM EST</td><td ID="encounter1type">Office Visit</td><td><p>North [REDACTED] Nephrology Consultants</p><p>[REDACTED][REDACTED]</p><p>Suite B</p><p>[REDACTED], GA 30607</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED][REDACTED]</p><p>Ste B</p><p>[REDACTED], GA 30607</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td><content>Stage 3b chronic kidney disease (CMS-HCC) (Primary Dx); <br/>Hypertension; <br/>Coronary arteriosclerosis, not otherwise specified; <br/>History of myocardial infarction; <br/>Atrial flutter, not otherwise specified (CMS-HCC); <br/>Pure hypercholesterolemia, not otherwise specified; <br/>Paroxysmal atrial fibrillation (CMS-HCC); <br/>Gastroesophageal reflux disease; <br/>Arteriosclerotic vascular disease; <br/>Hypercalcemia; <br/>Essential hypertension; <br/>Systolic heart failure, not otherwise specified (CMS-HCC); <br/>Hypernatremia; <br/>Hyperparathyroidism due to renal insufficiency (CMS-HCC)</content></td></tr></tbody></table></div><h3><a name="id2" href="#toc">Social History</a></h3><div><table ID="sochist18"><colgroup><col width="25%" span="2"/><col width="13%"/><col width="12%"/><col width="25%"/></colgroup><thead><tr><th>Tobacco Use</th><th>Types</th><th>Packs/Day</th><th>Years Used</th><th>Date</th></tr></thead><tbody><tr><td>Smoking Tobacco: Former</td><td/><td ID="sochist18packsperday"/><td/><td/></tr><tr ID="sochist18smokeless" class="xRowAlt"><td>Smokeless Tobacco: Never</td><td/><td/><td/><td/></tr></tbody></table><table><colgroup><col width="25%" span="2"/><col width="50%"/></colgroup><thead><tr><th>Alcohol Use</th><th>Standard Drinks/Week</th><th>Comments</th></tr></thead><tbody><tr><td ID="alcoholStatus">Never</td><td>0 (1 standard drink = 0.6 oz pure alcohol)</td><td/></tr></tbody></table><table><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Sex and Gender Information</th><th>Value</th><th>Date Recorded</th></tr></thead><tbody><tr ID="BirthSex21"><td>Sex Assigned at Birth</td><td ID="BirthSex21Value">Not on file</td><td/></tr><tr ID="GenderIdentity19"><td>Gender Identity</td><td ID="GenderIdentity19Value">Not on file</td><td/></tr><tr ID="SexualOrientation20"><td>Sexual Orientation</td><td ID="SexualOrientation20Value">Not on file</td><td/></tr></tbody></table>documented as of this encounter</div><h3><a name="id3" href="#toc">Last Filed Vital Signs</a></h3><div><table><colgroup><col width="25%" span="4"/></colgroup><thead><tr><th>Vital Sign</th><th>Reading</th><th>Time Taken</th><th>Comments</th></tr></thead><tbody><tr class="xRowNormal"><td class="xcellHeader">Blood Pressure</td><td><span class="content_span">160</span>/<span class="content_span">100</span></td><td>[REDACTED] 10:49 AM EST</td><td/></tr><tr ID="pulse_5749199340" class="xRowAlt"><td class="xcellHeader">Pulse</td><td>73</td><td>[REDACTED] 10:49 AM EST</td><td/></tr><tr ID="temp_" class="xRowNormal"><td class="xcellHeader">Temperature</td><td>-</td><td>-</td><td/></tr><tr ID="resp_" class="xRowAlt"><td class="xcellHeader">Respiratory Rate</td><td>-</td><td>-</td><td/></tr><tr ID="SpO2_" class="xRowNormal"><td class="xcellHeader">Oxygen Saturation</td><td>-</td><td>-</td><td/></tr><tr ID="inhaled_" class="xRowAlt"><td class="xcellHeader">Inhaled Oxygen Concentration</td><td>-</td><td>-</td><td/></tr><tr ID="weight_5749199340" class="xRowNormal"><td class="xcellHeader">Weight</td><td>59.9 kg (132 lb)</td><td>[REDACTED] 10:49 AM EST</td><td/></tr><tr ID="height_" class="xRowAlt"><td class="xcellHeader">Height</td><td>-</td><td>-</td><td/></tr><tr ID="bmi_5749199340" class="xRowNormal"><td class="xcellHeader">Body Mass Index</td><td>21.97</td><td>[REDACTED] 10:27 AM EST</td><td/></tr></tbody></table>documented in this encounter</div><h3><a name="id4" href="#toc">Patient Instructions</a></h3><div><ul><li>Patient Instructions: <ul><li><p> <span class="xLabel">[REDACTED], MD - [REDACTED] 10:00 AM EST</span></p><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>2 weeks nurse visit</content><br/><span class="xLabel">Electronically signed by [REDACTED], MD at [REDACTED]  9:12 AM MST</span><br/><br/></li></ul></li></ul>documented in this encounter</div><h3><a name="id5" href="#toc">Progress Notes</a></h3><div><ul><li>[REDACTED], MD - [REDACTED] 10:00 AM EST: <content><content><span class="xLabel">Formatting of this note is different from the original.</span><br/><span class="xLabel">Images from the original note were not included.</span><br/>Nephrology follow-up note;<br/>Primary Care Physician: [REDACTED] <br/>Date of visit;:  [REDACTED]<br/>Nephrology attending attestation;<br/>Pt is  evaluated in colloboration with NP.  patient care discussed  with NP.  I have confirmed the significant findings . I have supervised the formulation of the treatment plan and have reviewed all elements of this note and made amendments as needed to reflect my personal evaluation. I have also personally reviewed data, labs and studies. I agree with the documented findings and treatment plan.<br/>History of Present Illness:<br/>[REDACTED] is a [REDACTED]. female presenting with stage 3a   Chronic kidney disease. Blood pressure noted to be elevated in office. Caregiver advised that blood pressure medications were taken prior to visit. He also voiced that he had a follow up appointment [REDACTED] with cardiologist but it was rescheduled. Patient was advised to reschedule as soon as possible. Patient  has no complaints.  Creatinine was 1.39 with previous 1.81 and EGFR of 40 with previous 30.   Her most recent lab work reviewed at her primary care physician's office. Urinalysis essentially normal.  Protein to creatinine ratio has improved as well.  Patient offers no new complaints.  Her medications are reviewed and reconciled.<br/>Review of Systems:<br/>Review of Systems <br/>Constitutional: Negative.  <br/>Respiratory: Negative for cough and shortness of breath.  <br/>Cardiovascular: Negative for chest pain and leg swelling. <br/>Genitourinary: Negative for dysuria and flank pain. <br/><br/>Physical Exam:<br/>BP (!) 160/100  | Pulse 73  | BMI 21.97 kg/m²  <br/>Physical Exam<br/>Constitutional:  <br/>   Comments: Thin, small frame black female.  <br/>HENT: <br/>   Head: Normocephalic and atraumatic. <br/>Eyes: <br/>   Extraocular Movements: EOM normal. <br/>   Conjunctiva/sclera: Conjunctivae normal. <br/>Cardiovascular: <br/>   Rate and Rhythm: Normal rate and regular rhythm. <br/>Pulmonary: <br/>   Effort: Pulmonary effort is normal. <br/>   Breath sounds: Normal breath sounds. <br/>Genitourinary:<br/>   Comments: No flank pain<br/>Musculoskeletal: <br/>   Cervical back: Normal range of motion and neck supple. <br/>Neurological: <br/>   Mental Status: She is alert and oriented to person, place, and time. <br/>Psychiatric:    <br/>   Mood and Affect: Mood and affect normal. <br/><br/>Medications:<br/><br/>Current Outpatient Medications: <br/>•  amiodarone (PACERONE) 200 MG tablet, Take 200 mg by mouth 1 (one) time each day, Disp: , Rfl: <br/>•  amLODIPine (NORVASC) 5 MG tablet, Take 1 tablet (5 mg total) by mouth 1 (one) time each day, Disp: 30 tablet, Rfl: 3<br/>•  aspirin (ST [REDACTED]) 81 MG EC tablet, Take 81 mg by mouth, Disp: , Rfl: <br/>•  atorvastatin (LIPITOR) 40 MG tablet, Take 1 tablet by mouth 1 (one) time each day, Disp: , Rfl: <br/>•  Eliquis 5 MG tablet, Take 5 mg by mouth 2 (two) times a day, Disp: , Rfl: <br/>•  hydrALAZINE (APRESOLINE) 100 MG tablet, , Disp: , Rfl: <br/>•  isosorbide dinitrate (ISORDIL) 20 MG tablet, Take 20 mg by mouth 3 (three) times a day, Disp: , Rfl: <br/>•  lisinopril (PRINIVIL) 10 MG tablet, , Disp: , Rfl: <br/>•  memantine (NAMENDA) 10 MG tablet, Take 1 tablet by mouth 1 (one) time each day, Disp: , Rfl: <br/>•  metoprolol succinate XL (TOPROL-XL) 25 MG 24 hr tablet, Take 25 mg by mouth 1 (one) time each day, Disp: , Rfl: <br/>•  nitroglycerin (NITRODUR) 0.4 MG/HR, Place 1 patch on the skin 1 (one) time each day, Disp: , Rfl: <br/>•  nystatin (MYCOSTATIN) cream, Apply 1 application topically 2 times daily, Disp: , Rfl: <br/>•  triamcinolone (KENALOG) 0.1 % cream, Apply 1 application topically 2 times daily, Disp: , Rfl: <br/>•  hydrALAZINE (APRESOLINE) 100 MG tablet bid , , Disp: , Rfl: <br/><br/> <br/>[REDACTED] Medication Changes <br/> <br/> <br/> Accurate as of [REDACTED] 11:59 PM. If you have any questions, ask your nurse or doctor. <br/> <br/> <br/> <br/>START taking these medications  <br/>amLODIPine 5 MG tablet<br/>Commonly known as: NORVASC<br/>Take 1 tablet (5 mg total) by mouth 1 (one) time each day<br/> <br/> <br/>Modified Meds  <br/>* hydrALAZINE 50 MG tablet<br/>Commonly known as: APRESOLINE<br/>What changed: Another medication with the same name was removed. Continue taking this medication, and follow the directions you see here.<br/> <br/>* hydrALAZINE 100 MG tablet<br/>Commonly known as: APRESOLINE<br/>What changed: Another medication with the same name was removed. Continue taking this medication, and follow the directions you see here.<br/> <br/>lisinopril 10 MG tablet<br/>Commonly known as: PRINIVIL<br/>What changed: Another medication with the same name was removed. Continue taking this medication, and follow the directions you see here.<br/> <br/> <br/> * This list has 2 medication(s) that are the same as other medications prescribed for you. Read the directions carefully, and ask your doctor or other care provider to review them with you. <br/> <br/> <br/> <br/>Discontinued  <br/>sulfamethoxazole-trimethoprim 400-80 MG per tablet<br/>Commonly known as: BACTRIM<br/> <br/> <br/> <br/>Where to Get Your Medications <br/> <br/>These medications were sent to Walmart Pharmacy 1400 - [REDACTED], [REDACTED] - 1911 [REDACTED] BRIDGE PKWY  1911 [REDACTED][REDACTED] <br/> Phone: [REDACTED] <br/>· amLODIPine 5 MG tablet<br/> <br/><br/>Labs and Imaging:<br/>Labs reviewed that was completed at PCP office; 022723;<br/>Glucose, Serum/Plasma 70 - 99 mg/dL 76  92 R   88 R  101 High  R    79 R  <br/>Urea nitrogen, Serum/Plasma (BUN) 8 - 27 mg/dL 22  24   27  19    18  <br/>Creatinine, Serum/Plasma 0.57 - 1.00 mg/dL 1.39 High   1.81 High    2.03 High   1.65 High     1.45 High   <br/>Estimated Glomerular Filtration Rate (eGFR) &gt;59 mL/min/1.73 40 Low   30 Low    26 Low       <br/>Urea nitrogen/Creatinine, Serum/Plasma 12 - 28 16  13   13  12    12  <br/>Sodium, Serum/Plasma 134 - 144 mmol/L 148 High   145 High    141  142    146 High   <br/>Potassium, Serum/Plasma 3.5 - 5.2 mmol/L 3.6  3.6   3.9  3.2 Low     3.6  <br/>Chloride, Serum/Plasma 96 - 106 mmol/L 110 High   105   99  101    109 High   <br/>Carbon dioxide CO2), total, Serum/Plasma 20 - 29 mmol/L 24  25   24  24    23  <br/>Calcium, Serum/Plasma 8.7 - 10.3 mg/dL 9.7  10.2  10.3 High  R, CM  10.1  10.2   9.5 R, CM  9.6  <br/>Phosphate, Serum/Plasma 3.0 - 4.3 mg/dL 3.4  3.3   3.5  3.4    3.6  <br/>Albumin, Serum/Plasma 3.7 - 4.7 g/dL 3.5 Low   4.3   4.3  4.1  3.6 R    <br/><br/>[REDACTED];<br/>Serum creatinine 1.20.<br/>Estimated GFR of 48 mm/min.<br/>Glucose 103<br/>Uric acid 3.3<br/>Phosphorus 4.0.<br/>Protein to creatinine ratio; 249 mg/g.<br/>PTH of 225<br/>25-hydroxy vitamin D 45.<br/>Urinalysis essentially normal<br/><br/>Assessment/Plan  <br/> <br/><br/>#  Essential hypertension.   <br/>Advised low-salt diet. Started Amlodipine 5 mg daily. Goal blood pressure less than 140/90. Blood pressure elevated in office [REDACTED]. Caregiver advises blood pressure up and down at home.  Hydralazine dose was increased to 100 mg p.o. twice daily.  Continue other antihypertensive medication include metoprolol 25 mg daily and lisinopril 10 mg p.o. daily.  Strict 2 g sodium diet is encouraged.  Advise to keep a log for two weeks and bring to office visit [REDACTED].<br/> <br/>#Acute kidney injury:<br/>Creatinine is 1.39 improvement from previous 1.81. Her risk factors for kidney disease include longstanding hypertension, poor fluid intake and smoking which can cause vascular disease.<br/>Patient also has history of poor oral fluid intake.I have encouraged her to drink more fluids. Recent protein to creatinine ratio was 144 mg/g. She denies any urinary symptoms<br/>Renal ultrasound in [REDACTED] showed small kidneys with no hydronephrosis<br/>SPEP showed no M spike<br/>  Advised to increase water intake.<br/>If creatinine  worsen we will discontinue lisinopril. Was also advised to avoid nephrotoxic medications like NSAIDs and also let us know if there is any changes in medications.<br/><br/>#Secondary Hyperparthyrodisim<br/>Her most recent calcium level is 9.7 with previous  10.2  Patient currently not taking any Tums or vitamin D.   She also has history of poor fluid intake.    PTH level will be treated before next visit .<br/>Vitamin D level at 34.  SPEP showed no M spike<br/>Calcium level now at 9.7 and phosphorus 3.4<br/> <br/>#Coronary artery disease: On aspirin, Plavix and statin.  Currently denies any chest pain<br/> <br/>#Atrial fibrillation: Diagnosed during hospital admission in [REDACTED].  Now on metoprolol 25 mg daily and amiodarone.  On Eliquis. Advised to reschedule appt with cardiologist soon<br/> <br/>#Dementia: Currently on memantine<br/> <br/>#Hypokalemia: Noted during her hospital admission in [REDACTED].  Likely etiology is recurrent vomiting.  K now 3.6 with previous 4.0.  <br/> #Hypernatremia;<br/>Recent sodium level is 148.  Patient courage to drink 1800 mL of fluid per 24 hours.  We will recheck sodium level [REDACTED]..<br/>#Pyelonephritis: Noted in both kidneys during her hospital admission [REDACTED] when she presented with flank pain.  CT demonstrated stranding in both kidneys.   Currently denies any symptoms<br/> <br/> Mixed hyperlipidemia<br/>Goal LDL less than 100 in patient's with chronic kidney disease to minimize atherosclerotic events.  Currently patient is on atorvastatin.  Further management deferred to PCP. <br/> <br/>#GERD: On omeprazole<br/><br/>Recommendations:<br/>Orders Placed This Encounter <br/>Procedures <br/>• VITAMIN D 25-HYDROXY, D2+D3 <br/>  Standing Status:   Future <br/>  Number of Occurrences:   1 <br/>  Standing Expiration Date:   [REDACTED] <br/>• *Renal Function Panel (RFP) <br/>  Standing Status:   Future <br/>  Number of Occurrences:   1 <br/>  Standing Expiration Date:   [REDACTED] <br/>• Albumin/Creatinine Ratio, Random, Urine <br/>  Standing Status:   Future <br/>  Number of Occurrences:   1 <br/>  Standing Expiration Date:   [REDACTED] <br/><br/>Future Appointments<br/>Future Appointments <br/>Date Time Provider Department Center <br/>[REDACTED] 10:45 AM [REDACTED][REDACTED] E0239S05 EHR0239 <br/>[REDACTED] 10:00 AM [REDACTED], MD E0239S05 EHR0239 <br/></content><br/><span class="xLabel">Electronically signed by [REDACTED], MD at [REDACTED]  8:48 PM MST</span><br/></content></li></ul>documented in this encounter</div><h3><a name="id6" href="#toc">Plan of Treatment</a></h3><div><table><span style="font-weight:bold; ">Upcoming Encounters</span><colgroup><col width="10%"/><col width="15%"/><col width="25%" span="3"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter41" class="xRowNormal"><td>[REDACTED] 10:45 AM EST</td><td ID="encounter41type">Office Visit</td><td><p>North [REDACTED] Nephrology Consultants</p><p>[REDACTED][REDACTED]</p><p>Suite B</p><p>[REDACTED]</p><p>[REDACTED]</p></td><td><p>Bian, Jinghua, NP</p><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td/></tr><tr ID="encounter40" class="xRowAlt"><td>[REDACTED]  1:30 PM EDT</td><td ID="encounter40type">Office Visit</td><td><p>[REDACTED][REDACTED] Nephrology Consultants</p><p>[REDACTED][REDACTED]</p><p>Suite B</p><p>[REDACTED]</p><p>[REDACTED]</p></td><td><p>Bian, Jinghua, NP</p><p>[REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td/></tr></tbody></table><table><span style="font-weight:bold; ">Scheduled Orders</span><colgroup><col width="25%"/><col width="15%"/><col width="10%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Name</th><th>Type</th><th>Priority</th><th>Associated Diagnoses</th><th>Order Schedule</th></tr></thead><tbody><tr ID="procedure43"><td><span class="content_span">Renal Function Panel (RFP)</span></td><td>Lab</td><td>Routine</td><td><p>Stage 3b chronic kidney disease (CMS-HCC)</p></td><td ID="procedure43schedule">1 Occurrences starting [REDACTED] until [REDACTED]</td></tr><tr ID="procedure44"><td><span class="content_span">Total Protein w/ Creatinine, Urine, Random</span></td><td>Lab</td><td>Routine</td><td><p>Stage 3b chronic kidney disease (CMS-HCC)</p></td><td ID="procedure44schedule">1 Occurrences starting [REDACTED] until [REDACTED]</td></tr><tr ID="procedure45"><td><span class="content_span">Vitamin D, 25-Hydroxy, Serum</span></td><td>Lab</td><td>Routine</td><td><p>Stage 3b chronic kidney disease (CMS-HCC)</p></td><td ID="procedure45schedule">1 Occurrences starting [REDACTED] until [REDACTED]</td></tr><tr ID="procedure46"><td><span class="content_span">PTH Intact w/o Calcium, Serum</span></td><td>Lab</td><td>Routine</td><td><p>Hyperparathyroidism due to renal insufficiency (CMS-HCC)</p></td><td ID="procedure46schedule">1 Occurrences starting [REDACTED] until [REDACTED]</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id7" href="#toc">Visit Diagnoses</a></h3><div><table><colgroup><col width="100%"/></colgroup><thead><tr><th>Diagnosis</th></tr></thead><tbody><tr ID="vdx2" class="xRowNormal"><td><p><span class="content_span">Stage 3b chronic kidney disease (CMS-HCC)</span><span class="content_span"> - Primary</span></p></td></tr><tr ID="vdx3" class="xRowAlt"><td><p><span class="content_span">Hypertension</span></p></td></tr><tr ID="vdx4" class="xRowNormal"><td><p><span class="content_span">Coronary arteriosclerosis, not otherwise specified</span></p></td></tr><tr ID="vdx5" class="xRowAlt"><td><p><span class="content_span">History of myocardial infarction</span></p></td></tr><tr ID="vdx6" class="xRowNormal"><td><p><span class="content_span">Atrial flutter, not otherwise specified (CMS-HCC)</span></p></td></tr><tr ID="vdx7" class="xRowAlt"><td><p><span class="content_span">Pure hypercholesterolemia, not otherwise specified</span></p></td></tr><tr ID="vdx8" class="xRowNormal"><td><p><span class="content_span">Paroxysmal atrial fibrillation (CMS-HCC)</span></p></td></tr><tr ID="vdx9" class="xRowAlt"><td><p><span class="content_span">Gastroesophageal reflux disease</span></p></td></tr><tr ID="vdx10" class="xRowNormal"><td><p><span class="content_span">Arteriosclerotic vascular disease</span></p></td></tr><tr ID="vdx11" class="xRowAlt"><td><p><span class="content_span">Hypercalcemia</span></p></td></tr><tr ID="vdx12" class="xRowNormal"><td><p><span class="content_span">Essential hypertension</span></p></td></tr><tr ID="vdx13" class="xRowAlt"><td><p><span class="content_span">Systolic heart failure, not otherwise specified (CMS-HCC)</span></p></td></tr><tr ID="vdx14" class="xRowNormal"><td><p><span class="content_span">Hypernatremia</span></p></td></tr><tr ID="vdx15" class="xRowAlt"><td><p><span class="content_span">Hyperparathyroidism due to renal insufficiency (CMS-HCC)</span></p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id8" href="#toc">Care Teams</a></h3><div><table ID="ct56"><colgroup><col width="25%" span="3"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Team Member</th><th>Relationship</th><th>Specialty</th><th>Start Date</th><th>End Date</th></tr></thead><tbody><tr class="xRowNormal"><td><p>[REDACTED]</p><p>NPI: [REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td>PCP - General</td><td>Internal Medicine</td><td>[REDACTED]</td><td/></tr></tbody></table>documented as of this encounter</div><br/><br/>
</body></html>